[Federal Register Volume 65, Number 135 (Thursday, July 13, 2000)]
[Notices]
[Page 43374]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-17695]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


White House Commission on Complementary and Alternative Medicine 
Policy; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. appendix 2), notice is given of the first meeting of 
the White House Commission on Complementary and Alternative Medicine 
Policy. The purpose of the meeting is to convene the Commission and to 
begin receiving public testimony from individuals and organizations 
interested in the subject of federal policy regarding complementary and 
alternative medicine. Comments received at the meeting will be used by 
the Commission to identify and frame the issues and develop the agenda 
for subsequent meetings. Comments should focus on the following issues:
    (1) The education and training of health care practitioners in 
complementary and alternative medicine;
    (2) Coordinated research to increase knowledge about complementary 
and alternative medicine practices and products;
    (3) The provision to health care professionals of reliable and 
useful information about complementary and alternative medicine that 
can be made readily accessible and understandable to the general 
public; and
    (4) Guidance for appropriate access to and delivery of 
complementary and alternative medicine.
    Some Commission members may participate by telephone conference. 
The meeting is open to the public and opportunities for statements by 
the public will be provided on July 14, from 11:30 a.m.-12:30 p.m.
    Name of Committee: White House Commission on Complementary and 
Alternative Medicine Policy.
    Date: July 13-14, 2000.
    Time: July 13--2:00 p.m.-5:30 p.m. July 14--8:30 a.m.-5:00 p.m.
    Place: Hubert H. Humphrey Building, Room 800, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Contact Person: Stephen Groft, Pharm. D., Executive Director, 6701 
Rockledge Drive, Room 1010, Bethesda, MD 20817-1813, Phone: (301) 435-
6199, Fax: (301) 480-1691.
    Because of the need to obtain the views of the members as soon as 
possible and because of the early deadline for the report(s) required 
of the Commission, this notice is being provided at the earliest 
possible time.
    Supplementary Information: The President established the White 
House Commission on Complementary and Alternative Medicine Policy on 
March 7, 2000 by Executive Order 13147. The mission of the White House 
Commission on Complementary and Alternative Medicine Policy is to 
provide a report, through the Secretary of the Department of Health and 
Human Services, on legislative and administrative recommendations for 
assuring that public policy maximizes the benefits of complementary and 
alternative medicine to Americans.

Public Participation

    The meeting is open to the public with attendance limited by the 
availability of space on a first come, first serve basis. Members of 
the public who wish to present oral statements should contact Dr. 
Stephen C. Groft by telephone, fax, or mail as shown above as soon as 
possible, but at least 4 days before the meeting. A one-page summary of 
the presentation should accompany any request. The chairperson will 
reserve time for presentations by persons requesting to speak and asks 
that oral statements be limited to five minutes. The order of persons 
wanting to make a statement will be assigned in the order in which 
requests are received.
    Individuals unable to make oral presentations can mail their 
written comments to the staff office of the Commission at least 4 
business days prior to the meeting for distribution to the Commission 
and inclusion in the public record.
    Any person attending the meeting who has not requested an 
opportunity to speak in advance of the meeting will be allowed to make 
a brief oral presentation at the conclusion of the meeting, if time 
permits, at the chairperson's discretion.
    Due to time constraints, only one representative from each 
organization will be allowed to present oral testimony.
    Persons needing special assistance, such as sign language 
interpretation or other special accommodations, should contact the 
Commission staff at the address or telephone number listed below as 
soon as possible.

    Dated: July 6, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-17695 Filed 7-12-00; 8:45 am]
BILLING CODE 4140-01-M